Inactive Instrument

Exactus Inc Stock OTC Bulletin Board

US30066P1021

Pharmaceuticals

End-of-day quote OTC Bulletin Board
- ^USD	-

11-18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/05/24	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Exactus, Inc. is a healthcare company. The Company is focused on manufacturing hemp derived Cannabidiol (CBD) products. It sells its CBD products through its Exactus brand and white label products to third-party resellers. It is also engaged in producing industrial hemp from farms in Oregon. Its products product line includes hemp flower, pre-rolled hemp flower, topicals, tinctures and concentrates. It also offers point-of-care diagnostic tools to analyze biometric markers in a drop of blood. Its FibriLyzer product provides solution to assess the fibrinolytic status of patients in a broad range of applications, including surgery, trauma, orthopedics, heart, stroke and chronic coronary disease management. Its MatriLyzer product detects the initial occurrence or the recurrence of cancer during routine office visits.

Employees

Sector

Pharmaceuticals

More about the company

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!

Market Cap	519K 453K 427K 388K 727K 49.8M 730K 5.12M 1.98M 25.32M 1.95M 1.91M 81.47M	P/E 2022	-0.11x	P/E 2023	-0.31x
Enterprise Value	22.05M 19.23M 18.15M 16.49M 30.89M 2.12B 31.02M 217M 83.92M 1.08B 82.83M 80.99M 3.46B	EV / Sales 2022	11.6x	EV / Sales 2023	10.1x
Free-Float	-	Yield 2022 *	-	Yield 2023	-

11-18	Panacea Life Sciences Holdings and Benivita Inc. Launch Benivita PLSH	CI
06/05/24	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
01/04/24	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01/04/24	Panacea Life Sciences Holdings, Inc. Auditor Raises 'Going Concern' Doubt	CI
15/11/23	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
05/10/23	Panacea Life Sciences Holdings, Inc. completed the acquisition of N7 Enterprises, Inc.	CI
02/10/23	Panacea Life Sciences Holdings, Inc. entered into an Asset Purchase Agreement to acquire PÜR LIFE Medical, Inc.	CI
30/09/23	Panacea Life Sciences Holdings, Inc. completed the acquisition of Nitro Kava & Kratom from Gary Wilder, Lizard Juice, LLC, N7 Enterprises, Inc. and New Age Distribution Corp. for $7.8 million.	CI
15/08/23	Panacea Life Sciences Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
02/08/23	Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	CI
10/07/23	Panacea Life Sciences Holdings, Inc. agreed to acquire Nitro Kava & Kratom.	CI
10/07/23	Panacea Life Sciences Holdings, Inc. entered into agreements acquire 8 Retail Locations in the Tampa, Florida.	CI
15/06/23	Panacea Life Sciences Holdings, Inc. Distribution Division Signs Exclusive Distribution Agreement with QR Joy to Distribute U.S. Top Fume Disposable Vape Devices in the U.K	CI

11-18	Panacea Life Sciences Holdings (OTCID: PLSH) and Benivita Inc. Launch Benivita PLSH -- a New Era in Direct-to-Consumer Virtual Benefits	PR
16/05/24	Panacea Life Sciences and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products	AQ
16/05/24	Panacea Life Sciences : and Sky Wellness Enter Agreement for Licensing, Marketing, Supply and Development of Sky Wellness CBD Products - Form 8-K	PU
05/10/23	Panacea Life Sciences Holdings, Inc. Completes Acquisition of N7 Enterprises With Eight Natural Health and Wellness Retail and One Distribution Center Locations in the Tampa, Florida area	AQ
02/10/23	Panacea Life Sciences Holdings, Inc. Continues Growth Trajectory with Acquisition of the PÜR LIFE Medical Franchise	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+0.04%	+3.34%	+51.12%	+101.82%	1,028B
JOHNSON & JOHNSON	-0.09%	+1.66%	+55.02%	+66.18%	651B
ABBVIE INC.	-0.02%	+2.66%	+18.91%	+71.47%	466B
ROCHE HOLDING AG	-1.22%	+3.66%	+36.44%	+38.32%	346B
NOVARTIS AG	-0.79%	+2.73%	+19.03%	+25.08%	266B
ASTRAZENECA PLC	+0.58%	+6.76%	+11.13%	+16.52%	259B
AMGEN INC.	+1.55%	+2.20%	+39.81%	+46.55%	208B
NOVO NORDISK A/S	+0.79%	+1.84%	-28.27%	-56.71%	191B
GILEAD SCIENCES, INC.	-0.52%	+4.45%	+32.12%	+98.51%	186B
Average	+0.20%	+2.82%	+26.15%	+45.30%	400.19B
Weighted average by Cap.	+0.23%	+2.81%	+35.15%	+61.76%

	2022	2023
Net sales	1.63M 1.42M 1.34M 1.22M 2.28M 156M 2.29M 16.05M 6.19M 79.37M 6.11M 5.98M 255M	2.38M 2.08M 1.96M 1.78M 3.34M 229M 3.35M 23.52M 9.08M 116M 8.96M 8.76M 374M
Net income	-9.14M -7.97M -7.53M -6.84M -12.81M -877M -12.86M -90.17M -34.8M -446M -34.34M -33.58M -1.44B	-8.02M -6.99M -6.6M -5.99M -11.23M -769M -11.28M -79.05M -30.51M -391M -30.11M -29.44M -1.26B
Net Debt	17.85M 15.57M 14.7M 13.35M 25.01M 1.71B 25.11M 176M 67.95M 871M 67.07M 65.58M 2.8B	21.53M 18.77M 17.73M 16.1M 30.16M 2.07B 30.29M 212M 81.94M 1.05B 80.88M 79.08M 3.38B

Exactus Inc Stock OTC Bulletin Board

Stocks

US30066P1021

Pharmaceuticals

Valuation: Exactus Inc

Latest news: Exactus Inc

Press Releases: Exactus Inc

Other Pharmaceuticals

Financials

Company Profile